Literature DB >> 18721868

Promoter characterization and regulation of expression of an imprinted gene SLC22A18AS.

Vineeta Bajaj1, Pooja Singhmar, Arun Kumar.   

Abstract

The SLC22A18/SLC22A18AS genes are a sense-antisense pair located at human chromosome segment 11p15.5. These genes are paternally imprinted: paternal alleles are silenced and maternal alleles are expressed. Although SLC22A18 is a well-characterized gene, very little is known regarding its antisense partner SLC22A18AS. We therefore sought to identify the potential cis-regulating elements including the promoter of this gene, differentially methylated regions (DMRs) and the translation of its putative ORF. Dual promoters (P1 and P2) were identified for this gene and both are devoid of consensus TATA and CCAAT boxes. However, the P1 promoter harbors a putative Sp1 binding site. Sp1 binds to the P1 promoter in vivo and positively regulates its activity. Promoter and CpG II island regions showed heavy methylation of CpG sites, but no DMRs were observed. Treatment of a non-SLC22A18AS expressing HuH7 cells with the methyltransferase inhibitor 5-aza-2'-deoxycytidine restored expression of this gene. The histone deacetylase (HDAC) inhibitor Trichostatin-A, on the other hand, failed to induce its expression. We suggest that the expression of this gene is methylation-dependent, but histone acetylation-independent. This gene was found to be translated with a cytoplasmic localization. The present data will help to understand the regulation of this gene and its role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721868     DOI: 10.1016/j.gene.2008.07.032

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.

Authors:  Mohammad Iqbal Rather; Shivananda Swamy; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

2.  Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Hong Zhang; Zhi-An Zhu; Zhi-Qiang Li; Pu-Cha Jiang
Journal:  J Transl Med       Date:  2011-09-21       Impact factor: 5.531

3.  [Expression and its clinical significance of SLC22A18 in non-small cell lung cancer].

Authors:  Ming Lei; Qingshu Cheng; Yachao Zhao; Tao Liu; Xuejiao Wang; Yingchun Deng; Jing Yang; Zhipei Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-01

4.  The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients.

Authors:  José Francisco Noguera-Uclés; Laura Boyero; Ana Salinas; Juan Antonio Cordero Varela; Johana Cristina Benedetti; Reyes Bernabé-Caro; Amparo Sánchez-Gastaldo; Miriam Alonso; Luis Paz-Ares; Sonia Molina-Pinelo
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

5.  Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.

Authors:  Thejaswini Venkatesh; Mathighatta Nagaraj Nagashri; Shivananda S Swamy; S M Azeem Mohiyuddin; Kodaganur S Gopinath; Arun Kumar
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

6.  Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin.

Authors:  Shalmali Avinash Pradhan; Mohammad Iqbal Rather; Ankana Tiwari; Vishwanath Kumble Bhat; Arun Kumar
Journal:  Nucleic Acids Res       Date:  2014-04-19       Impact factor: 16.971

7.  Genome-wide association study of body fat distribution traits in Hispanics/Latinos from the HCHS/SOL.

Authors:  Anne E Justice; Kristin Young; Stephanie M Gogarten; Tamar Sofer; Misa Graff; Shelly Ann M Love; Yujie Wang; Yann C Klimentidis; Miguel Cruz; Xiuqing Guo; Fernando Hartwig; Lauren Petty; Jie Yao; Matthew A Allison; Jennifer E Below; Thomas A Buchanan; Yii-Der Ida Chen; Mark O Goodarzi; Craig Hanis; Heather M Highland; Willa A Hsueh; Eli Ipp; Esteban Parra; Walter Palmas; Leslie J Raffel; Jerome I Rotter; Jingyi Tan; Kent D Taylor; Adan Valladares; Anny H Xiang; Lisa Sánchez-Johnsen; Carmen R Isasi; Kari E North
Journal:  Hum Mol Genet       Date:  2021-11-01       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.